We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.35% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IAA
326
DELISTED
IAA, Inc. Common Stock
IAA
| $35M | 0.07% |
+914,152
| New | +$37.6M |
|
327
Annaly Capital Management
NLY
$16.9B
| $34.8M | 0.07% |
1,236,503
+955,326
| +340% | +$28.4M |
|
|
LGV
328
DELISTED
Longview Acquisition Corp. II
LGV
| $34.5M | 0.07% |
3,532,408
+274,990
| +8% | +$2.68M |
|
|
ARCH
329
DELISTED
Arch Resources, Inc.
ARCH
| $34.2M | 0.06% |
248,805
+128,884
| +107% | +$15.3M |
|
330
Element Solutions
ESI
$9.12B
| $34.2M | 0.06% |
1,560,197
-210,598
| -12% | -$4.85M |
|
331
Parker-Hannifin
PH
$125B
| $34.1M | 0.06% |
120,344
+6,053
| +5% | +$1.83M |
|
332
Zebra Technologies
ZBRA
$12.4B
| $34.1M | 0.06% |
82,530
+50,072
| +154% | +$23M |
|
333
Ralph Lauren
RL
$22.2B
| $34M | 0.06% |
299,848
-225,206
| -43% | -$26.5M |
|
334
Ulta Beauty
ULTA
$20.4B
| $33.8M | 0.06% |
84,890
-117,457
| -58% | -$44.2M |
|
335
CALL
Invesco QQQ Trust
QQQ
$455B
| $33.5M | 0.06% |
92,300
-77,300
| -46% | -$27.5M |
|
336
Gentex
GNTX
$4.88B
| $33.4M | 0.06% |
1,143,340
-98,055
| -8% | -$3.05M |
|
337
Louisiana-Pacific
LPX
$5.2B
| $33.2M | 0.06% |
534,403
-5,540
| -1% | -$382K |
|
338
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $33.1M | 0.06% |
480,900
+178,400
| +59% | +$13M |
|
|
NVRO
339
DELISTED
NEVRO CORP.
NVRO
| $33M | 0.06% |
456,706
+295,914
| +184% | +$21.3M |
|
340
TSMC
TSM
$2.09T
| $32.5M | 0.06% |
312,142
-157,124
| -33% | -$18.4M |
|
|
EMBJ
341
Embraer S.A. ADS
EMBJ
$11.6B
| $32.5M | 0.06% |
2,573,991
-3,247
| -0.1% | -$46.1K |
|
342
HDFC Bank
HDB
$119B
| $32.4M | 0.06% |
1,057,582
+864,422
| +448% | +$28.1M |
|
|
XYZ
343
CALL
Block Inc
XYZ
$45.9B
| $32.3M | 0.06% |
238,400
+207,000
| +659% | +$25.1M |
|
344
FerroAtlántica
GSM
$628M
| $32.2M | 0.06% |
4,182,362
-288,890
| -6% | -$1.97M |
|
|
FVIV
345
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
| $32M | 0.06% |
3,266,946
| – | – |
|
|
346
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $31.8M | 0.06% |
461,500
+107,600
| +30% | +$7.84M |
|
347
Berkshire Hathaway Class A
BRK.A
$1.07T
| $31.7M | 0.06% |
60
+59
| +5,900% | +$28.6M |
|
348
F5
FFIV
$22.1B
| $31.6M | 0.06% |
151,370
-19,577
| -11% | -$4.11M |
|
349
KBR
KBR
$4.68B
| $31.6M | 0.06% |
577,287
+326,313
| +130% | +$15.9M |
|
350
Enphase Energy
ENPH
$4.84B
| $31.6M | 0.06% |
156,456
+31,883
| +26% | +$5.01M |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.